Villanova Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,829
Closed -$1.33M 61
2025
Q3
$1.33M Sell
32,829
-58,029
-64% -$1.92M 0.92% 51
2025
Q2
$2.32M Buy
90,858
+58,579
+181% +$1.28M 2.4% 10
2025
Q1
$2.02M Sell
32,279
-62,365
-66% -$1.39M 2% 17
2024
Q4
$1.99M Buy
94,644
+9,056
+11% +$210K 1.77% 24
2024
Q3
$1.93M Sell
85,588
-31,210
-27% -$603K 2.06% 18
2024
Q2
$1.96M Buy
+116,798
New +$1.88M 2.08% 13

Other funds holding PAHC

Villanova Investment Management's PAHC Position: Q4 2025 in Review

Villanova Investment Management sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 32,829 shares — an estimated $1.33M sold.

Villanova Investment Management first reported a position in PAHC in Q2 2024 and held it in 6 quarters. The position peaked at $2.32M in Q2 2025. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

  • Villanova Investment Management reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
  • Villanova Investment Management sold 32,829 Phibro Animal Health shares in Q4 2025, an estimated $1.33M.
  • Villanova Investment Management first reported a position in Phibro Animal Health in Q2 2024 and held it in 6 quarters.
  • Villanova Investment Management's Phibro Animal Health position peaked at $2.32M in Q2 2025.
  • 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on Villanova Investment Management's 13F filing for Q4 2025, filed 24 Feb 2026.